Company: PIII
Filing Date: 2025-03-03
Form Type: DEF 14A
Source: 0001140361-25-006787
Chunk: 2

Company: P3 Health Partners Inc.
Filing Date: 2025-03-03
Form: DEF 14A
Chunk 2
---
 2 APPROVAL OF AN ADJOURNMENT OF THE SPECIAL MEETING                                          |     |   18 |
| STOCK OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT                                           |     |   19 |
| OTHER MATTERS                                                                                         |     |   23 |
| APPENDIX A                                                                                            |     |  A-1 |

#### TABLE OF CONTENTS

#### Forward-Looking Statements
This proxy statement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this proxy statement that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding the Company’s intent or ability to effect a Reverse Stock Split or regain compliance with any applicable Nasdaq listing requirements. These statements are based on management’s current assumptions and are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including that the Reverse Stock Split may not be approved by the Company’s stockholders. For other important factors that could cause actual results to differ materially from the forward-looking statements in this proxy statement, please see the risks and uncertainties identified under the heading “Risks Associated with the Reverse Stock Split” in this Proxy Statement, and “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as updated by the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, each of which is available on the Company’s Investor Relations website at ir.p3hp.org and on the SEC website at www.sec.gov . All forward-looking statements reflect the Company’s beliefs and assumptions only as of the date of this proxy statement. The Company undertakes no obligation to update forward-looking statements to reflect future events or circumstances.

#### TABLE OF CONTENTS

#### P3 Health Partners Inc.

#### 2370 Corporate Circle, Suite 300

#### Henderson, Nevada 89074

### PROXY STATEMENT
**For the Special Meeting of Stockholders to be Held on Monday, March 31, 2025

This proxy statement is furnished in connection with the solicitation of proxies by the Board of Directors (the “Board”) of P3 Health Partners Inc. (“P3,” the “Company,” “we,” “us” or “our